Ronald R. Blanck, Director at TENAX THERAPEUTICS, INC. (TENX), bought 1,900 shares at $3.20 ($6K) on 2015-11-19, disclosed to the SEC on 2015-11-19.
Open-market purchase of $6k TENX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| TENX | SELL | 2017-11-20 | $5K | — | Filing → |
| TENX | BUY | 2015-11-19 | $15K | — | Filing → |
| TENX | BUY | 2015-01-20 | $7K | — | Filing → |